ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE

被引:0
|
作者
Guzauskas, G. F. [1 ]
Wang, B. C. M. [1 ]
Kinzel, A. [2 ]
Proescholdt, C. [3 ]
机构
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Novocure, Munich, Germany
[3] Novocure, Root, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P01.110
引用
收藏
页码:256 / 257
页数:2
相关论文
共 50 条
  • [21] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Farber, Ori
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 76 - 77
  • [22] EIGHTEEN YEARS OF EXPERIENCE WITH TREATMENT OF GLIOBLASTOMA USING TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM) IN A SINGLE CENTER
    Vymazal, Josef
    Novak, Tomas
    Slanina, Petr
    Kazda, Tomas
    Sroubek, Jan
    Klener, Jan
    Hrbac, Tomas
    Syrucek, Martin
    Rulseh, Aaron
    NEURO-ONCOLOGY, 2022, 24 : 143 - 143
  • [23] TUMOR TREATING FIELDS TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: A COST-EFFECTIVENESS ANALYSIS FOR SWEDEN
    Guzauskas, G. F.
    Wang, B. C. M.
    Kinzel, A.
    Proescholdt, C.
    NEURO-ONCOLOGY, 2018, 20 : 256 - 256
  • [24] SPARE Trial: Scalp Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (200 kHz) for Patients With Newly Diagnosed Glioblastoma
    Miller, R. C.
    Song, A. J.
    Ali, A.
    Bar-Ad, V.
    Martinez, N.
    Glass, J.
    Alnahhas, I.
    Andrews, D. W.
    Judy, K.
    Evans, J.
    Farrell, C.
    Werner-Wasik, M.
    Chervoneva, I.
    Ly, M.
    Palmer, J. D.
    Liu, H.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E594 - E595
  • [25] TUMOR TREATING FIELDS COMBINED WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: FINAL SAFETY AND EFFICACY RESULTS FROM A PILOT STUDY
    Grossman, R.
    Bokstein, F.
    Blumenthal, D.
    Ben Harush, C.
    Limon, D.
    Ram, Z.
    NEURO-ONCOLOGY, 2019, 21 : 84 - 84
  • [26] PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Stupp, Roger
    Idbaih, Ahmed
    Steinberg, David M.
    Read, William
    Toms, Steven
    Barnett, Gene
    Nicholas, Garth
    Kim, Chae-Yong
    Fink, Karen
    Salmaggi, Andrea
    Lieberman, Frank
    Zhu, Jay
    Taylor, Lynne
    Stragliotto, Giuseppe
    Hottinger, Andreas
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    Hegi, Monika E.
    Ram, Zvi
    NEURO-ONCOLOGY, 2016, 18 : 1 - 1
  • [27] COMPLIANCE AND TREATMENT DURATION PREDICT SURVIVAL IN A PHASE 3 EF-14 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ram, Zvi
    Kim, Chae-Yong
    Nicholas, Garth A.
    Toms, Steven
    NEURO-ONCOLOGY, 2017, 19 : 6 - 7
  • [28] Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma
    Song, Andrew
    Bar-Ad, Voichita
    Martinez, Nina
    Glass, Jon
    Andrews, David W.
    Judy, Kevin
    Evans, James J.
    Farrell, Christopher J.
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua D.
    Liu, Haisong
    Shi, Wenyin
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (03) : 653 - 661
  • [29] Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma
    Andrew Song
    Voichita Bar-Ad
    Nina Martinez
    Jon Glass
    David W. Andrews
    Kevin Judy
    James J. Evans
    Christopher J. Farrell
    Maria Werner-Wasik
    Inna Chervoneva
    Michele Ly
    Joshua D. Palmer
    Haisong Liu
    Wenyin Shi
    Journal of Neuro-Oncology, 2020, 147 : 653 - 661
  • [30] Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM)
    Cappelli, L.
    Kanyne, A.
    Pan, P. C.
    Cordova, J. S.
    Huang, J.
    Wang, T. J. C.
    Alnahhas, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E68 - E68